HIV-1 Incidence and Genetic Diversity in the Caribbean
HIV-1 Incidence and Genetic Diversity in the Caribbean
批准号:
6696111
负责人:
Farley R Cleghorn
金额:
$21.7万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2005-06-30
关键词:
中文摘要
描述(由申请人提供):将开展两个不同但高度相关的研究项目,以准确确定参与艾滋病毒疫苗试验网络(HVTN)的五个加勒比国家(牙买加、特立尼达、海地、多米尼加共和国和波多黎各)艾滋病毒感染高危人群中的艾滋病毒发病率和艾滋病毒分子多样性/重组。这些研究产生的数据将对第三阶段疫苗试验的实施至关重要。需要检验的假设是:1)对高危人群的横断面存档样本进行改良的敏感/不敏感(S/LS)分析,可以方便可靠地估计最近艾滋病毒的高发病率,以及2)主要的循环艾滋病毒亚型是B分支,很少或根本没有证据表明Poll基因的RT/Protease区域存在重组,这是重组最频繁的位置。此外,生成的数据将提供有关偶发(循环)艾滋病毒中常见的抗逆转录病毒耐药性突变的信息,我们预测这些突变将在这些主要接受治疗的幼稚人群中缺失。该小组是IHV/UMD的高级科学家,在该地区开展流行病学/病毒学合作研究方面经验丰富,并将与亨利·杰克逊基金会的艾滋病毒分子特征专家以及加勒比地区的临床艾滋病毒传播网络调查人员合作。这两个相关项目将利用现有的特征化血清/血浆收集,这些收集将在疾病预防控制中心IND的参与实验室IHV用S/LS分析进行分析,以提供发病率数据。使用两阶段算法来准确地表征事件样本,然后将在基因组的RT/蛋白酶区域中对至少50个事件样本(每个位点10个)进行测序,该区域通常包括重组断裂点。这一快速评估将使用一种新开发的技术对25/50(每个位点5个)全长基因组的子集进行确认,这些基因组将从从血清中提取的病毒RNA中进行测序。这些研究产生的数据将验证将这五个地点纳入疫苗和预防测试网络的理由,并有助于支持控制艾滋病毒传播的计划的证据基础。创新之处在于使用改进的S/LS检测算法快速确定发病率估计并准确识别事件样本,以及使用重叠RT PCR对事件血清(无细胞)样本中的病毒RNA进行全基因组测序。
英文摘要
DESCRIPTION (provided by applicant): Two distinct but highly related research projects will be conducted to accurately determine HIV incidence and HIV molecular diversity/recombination in populations at high risk of HIV infection in five Caribbean countries (Jamaica, Trinidad, Haiti, the Dominican Republic and Puerto Rico) participating in the HIV Vaccine Trials Network (HVTN). The data generated by these studies will be critical to implementation of Phase III vaccine trials. The hypotheses to be tested are 1) that recent high HIV-1 incidence can be conveniently and reliably estimated using a modified sensitive/less sensitive (S/LS) assay on archived crosssectionally collected samples from high-risk populations, and 2) that the predominant circulating HIV subtype is clade B, with little or no evidence of recombination in the RT/protease region of the pol gene, which is the most frequent site for recombination. In addition, the data generated will provide information about common anti-retroviral resistance mutations in incident (circulating) HIV that we predict will be absent in these largely treatment naive populations. The PI, a senior scientist at the IHV/UMD, is highly experienced in conducting collaborative epidemiologic/virologic studies in the region, and will collaborate with experts in HIV molecular characterization at the Henry Jackson Foundation, as well as clinical HVTN investigators in the Caribbean. These two related projects will utilize existing characterized serum/plasma collections that will be assayed with the S/LS assay at IHV, which is a participating laboratory in the IND held by CDC, to provide incidence data. Using a two-stage algorithm to accurately characterize the incident samples, at least 50 incident samples (10 per site) will then be sequenced in the RT/protease region of the genome that commonly includes recombination breakpoints. This rapid assessment will then be confirmed using a newly developed technique in a subset of 25/50 (5 per site) full-length genomes that will be sequenced from viral RNA extracted from serum. Data generated by these studies will validate the rationale for including these five sites in vaccine and prevention testing networks and help to bolster the evidence base for programs to control the spread of HIV. Innovation is presented in the use of a modified S/LS assay algorithm to rapidly ascertain incidence estimates and accurately identify incident samples, and in the use of overlapping RT PCR for full genome sequencing of viral RNA from incident serum (cell-free) samples.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRANSMISSION FACTORS FOR HIV-1 AND HTLV-1 IN TRINIDAD
-
批准号:3021900
-
项目类别:
-
资助金额:$0.05万
-
财政年份:1991
-
负责人:Farley R Cleghorn
-
依托单位:
TRANSMISSION FACTORS FOR HIV-1 AND HTLV-1 IN TRINIDAD
-
批准号:3021901
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1991
-
负责人:Farley R Cleghorn
-
依托单位:
TRANSMISSION FACTORS FOR HIV-1 AND HTLV-1 IN TRINIDAD
-
批准号:3021899
-
项目类别:
-
资助金额:$2.36万
-
财政年份:1990
-
负责人:Farley R Cleghorn
-
依托单位:
海外基金